Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-08-21

Clinical Trial Update: Relationship Between Serum β2-Microglobulin and Infiltration of CD8+ in the Tumor Tissue of Hodgkin's Lymphoma Patients

View source ↗

Summary

This completed clinical trial evaluated whether serum beta-2 microglobulin levels correlate with CD8+ T-cell infiltration in Hodgkin lymphoma tumor tissue.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Tishreen University | Conditions: Hodgkin Lymphoma | Status: COMPLETED